218 related articles for article (PubMed ID: 16609681)
1. Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis.
Hagiwara M; Yamagata K; Capaldi RA; Koyama A
Kidney Int; 2006 Apr; 69(7):1146-52. PubMed ID: 16609681
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis.
Shiiki H; Sasaki Y; Nishino T; Kimura T; Kurioka H; Fujimoto S; Dohi K
Pathobiology; 1998; 66(5):221-9. PubMed ID: 9732237
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
Diamond JR; Karnovsky MJ
J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
[TBL] [Abstract][Full Text] [Related]
4. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Grond J; Weening JJ; Elema JD
Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
[TBL] [Abstract][Full Text] [Related]
5. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
6. Glomerular metalloprotease activity modulates the development of focal segmental glomerulosclerosis.
Sagar S; Gibbons N; Valderrama E; Singhal PC
Clin Nephrol; 1995 Dec; 44(6):356-61. PubMed ID: 8719546
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
8. Smad3/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage.
Yu L; Liu Y; Wu Y; Liu Q; Feng J; Gu X; Xiong Y; Fan Q; Ye J
Cell Signal; 2014 Dec; 26(12):2979-91. PubMed ID: 25229402
[TBL] [Abstract][Full Text] [Related]
9. [Bone mesenchymal stem cell transplantation repairs glomerular podocytes in rats with puromycin aminonucleoside-induced nephrosis].
Yang HD; Dong C; Guan FJ; Gao LL; Zhao T; Feng BF
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):483-7. PubMed ID: 20540862
[TBL] [Abstract][Full Text] [Related]
10. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
11. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
12. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
13. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
Diamond JR; Pesek I
Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation.
Hotta O; Inoue CN; Miyabayashi S; Furuta T; Takeuchi A; Taguma Y
Kidney Int; 2001 Apr; 59(4):1236-43. PubMed ID: 11260383
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury.
Wang Z; Wei X; Zhang Y; Ma X; Li B; Zhang S; Du P; Zhang X; Yi F
Cell Physiol Biochem; 2009; 24(5-6):619-26. PubMed ID: 19910702
[TBL] [Abstract][Full Text] [Related]
16. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
Herrmann A; Tozzo E; Funk J
Exp Toxicol Pathol; 2012 Jan; 64(1-2):45-9. PubMed ID: 20591637
[TBL] [Abstract][Full Text] [Related]
17. Trpc6 inactivation confers protection in a model of severe nephrosis in rats.
Kim EY; Yazdizadeh Shotorbani P; Dryer SE
J Mol Med (Berl); 2018 Jul; 96(7):631-644. PubMed ID: 29785489
[TBL] [Abstract][Full Text] [Related]
18. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
20. Differences in puromycin aminonucleoside nephrosis in two rat strains.
Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
